In this article, we will discuss the 10 best fast-growing penny stocks to buy now.
Rate Cuts Are Around the Corner
September tends to be the worst month for the stock market, however 2024 might just be an outlier in history. Considering that the economy is doing worse than what was estimated earlier, the Fed needs to decide on a cut rate soon. We discussed this earlier in our article about the 10 Most Buzzing Stocks To Buy Now, here’s an excerpt from it:
“Investors are concerned that the FED will be slower to lower interest rates while inflation remains sticky and GDP growth begins to cool. Stovall expects three 25-basis point cuts this year, followed by another four in 2025. He thinks that while a 50 basis point cut is rare since it only ever happened twice, in 2001 and then 2007, it is still not unlikely given that the economy is worse than expected.
According to Stovall, investors need to be prepared for this increased volatility as the market digests the Fed’s actions and the potential impact on the economy. The market will likely remain uncertain until the Fed can find the right balance between slowing down the economy and stopping inflation, without causing a recession.”
Michael Feroli, JPMorgan’s chief US economist, recently discussed whether a 50 basis point cut is an overreaction. Feroli advocates for the Fed to implement a 50 basis point rate cut during its upcoming meeting on September 17-18, suggesting that this move would help return the economy to a neutral stance.
He thinks that although the economy is softening rather than collapsing, the Fed should not wait long enough for it to collapse before implementing a 50 basis point cut. The call for a significant rate cut comes in light of recent labor market data, and disappointing job growth, coupled with a downward revision of July’s figures, intensifying speculation regarding the Fed’s monetary policy direction.
Fed officials have been cautious in providing specific guidance regarding the size of the anticipated rate cut. Fed Chair Jerome Powell indicated that the central bank has largely succeeded in controlling inflation through high interest rates but expressed concerns about further weakening in the job market.
However, George Lagarias, chief economist at Forvis Mazars, believes that a 50 basis point rate cut by Fed this month could pose considerable risks to financial markets, and send a misleading signal about imminent recession risk. He thinks that unemployment alone does not translate into a recession, especially considering that China continues to deflate the global economy.
He advocates for a more measured approach, suggesting a quarter-point reduction instead of a 50 basis point cut, which he believes could imply a sense of urgency that may become a self-fulfilling prophecy. Lagarias says that unless there is a significant market disturbance, there is no cause for alarm, and a drastic cut could mislead both the markets and the economy.
According to CME’s FedWatch tool, 30% of market participants are expecting a 50 basis points cut while 70% are expecting a 25 basis point cut. Lagarias’ caution reflects a broader sentiment among economists who advise against hasty decisions that could destabilize financial markets.
Rate cuts are good for business and several small companies that have been under pressure due to higher rates could soar as interest rates come down. With that, let’s discuss the 10 best fast-growing penny stocks to buy now.
Methodology
To compile our list, we used a stock screener to screen for companies that are trading under $5 and have grown their earnings by double digits over the past year. We made an initial list of 25 stocks and then selected the ones that have grown their revenue by at least 30% over the past 3 years and are also popular among elite hedge funds and analysts. The stocks are ranked in ascending order of the number of hedge funds that have stakes in them, as of Q2 2024.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
10 Best Fast-Growing Penny Stocks to Buy Now
10. D-Market Elektronik Hizmetler Ve Ticaret Anonim Sirketi (NASDAQ:HEPS)
3-Year Revenue CAGR: 78.02%
Year-over-Year Revenue CAGR: 133.92%
Share Price as of September 5: $2.76
Number of Hedge Fund Holders: 7
D-Market Elektronik Hizmetler Ve Ticaret Anonim Sirketi (NASDAQ:HEPS) is a leading Turkish e-commerce platform, regarded as the Amazon of Turkey, that offers a range of products, from electronics to fashion, and operates a robust logistics network across the country. It has over 64 million members across 30 product categories, providing goods and services through its hybrid model, which combines first-party direct sales and a third-party marketplace.
The company’s innovative wallet, Hepsipay, has a user base of 15.7 million. It is well-positioned to become Turkey’s leading digital wallet, by enhancing customer retention and opening up new revenue streams through financial services.
D-Market Elektronik Hizmetler Ve Ticaret Anonim Sirketi (NASDAQ:HEPS) continues to expand its customer base and product offerings, recording a 22% increase in total orders, with gross merchandise value growing by 42.5% in the first quarter of 2024. There was also a 1.4% rise in active customers.
In FQ1, the company reported that its revenue improved 45% year-over-year to $344 million, despite Turkey’s challenging economic environment with nearly 70% annual inflation.
In late July this year, it announced a collaboration with Warner Bros. Discovery. As part of this, Premium members will receive a subscription to BluTV, a Turkish video-on-demand service recently acquired by Warner Bros. Discovery.
Turkey’s e-commerce sector is still in its early stages of digital adoption and presents a significant growth potential. The company’s earnings are expected to grow by 176.65% this year. Its strong revenue growth, profitability, financial position, and strategic market positioning make it a standout player. As of June 30, its stock was held by 7 hedge funds, with the largest stake being $10,827,672 by Hosking Partners.
9. Energy Fuels Inc. (NYSE:UUUU)
3-Year Revenue CAGR: 200.58%
Year-over-Year Revenue CAGR: 54.11%
Share Price as of September 5: $4.39
Number of Hedge Fund Holders: 11
Energy Fuels Inc. (NYSE:UUUU) is a mining company that extracts and sells uranium, a mineral used to create nuclear energy. It claims to have access to 70 million pounds of uranium and the potential to produce 6 million pounds annually and also produces other materials like vanadium and rare earth metals. The stock is held by 11 hedge funds, as of Q2 2024. The largest stake amounts to $9,223,229 by Bridgewater Associates.
Recently, the company successfully sold an additional 100,000 pounds of uranium on the spot market (for total proceeds of $8.59 million) and secured a new long-term sales contract with a U.S. nuclear utility at favorable pricing. Under this contract, it will deliver 270,000-330,000 pounds of uranium between 2026 and 2027, and potentially an additional 180,000-220,000 pounds until 2029.
It’s actively mining uranium from 3 of its conventional mines in preparation for a large-scale uranium processing campaign at its White Mesa Mill. This campaign is anticipated to commence later this quarter and continue through 2025 and 2026. It also entered into agreements to acquire 2 world-scale rare earth and heavy mineral sand projects.
As of June 30, 2024, the company held 938,000 pounds of U3O8 (a common chemical compound of uranium) and 25 tonnes of separated NdPr (two rare earth metals, neodymium, and praseodymium) in inventory.
In its second quarter, the company reported generating $8.71 million in revenue, with a 27.26% year-over-year improvement. The upcoming quarter is projected to have strong growth as well. Overall, the company is well-positioned for growth.
8. Immunitybio Inc. (NASDAQ:IBRX)
3-Year Revenue CAGR: 39.48%
Year-over-Year Revenue CAGR: 120.95%
Share Price as of September 5: $3.70
Number of Hedge Fund Holders: 13
Immunitybio Inc. (NASDAQ:IBRX) is a biotechnology company that focuses on developing new cancer treatments. It uses a specific approach called cellular immunotherapy which involves using the body’s immune system to fight cancer cells. 13 hedge funds were long in the company as of the second quarter of 2024.
In Q2, the company’s earnings per share missed analysts estimates by 33%, and it generated a $0.20 loss per share. However, this was an improvement from the $0.32 loss in Q2 2023. Revenue also missed estimates by 59%, and amounted to $1.05 million. Yet, the year-over-year revenue growth was 2,463.66%.
In August, the company started a new clinical trial to test ANKTIVA and AdHER2DC for endometrial cancer. ANKTIVA is a drug that helps the immune system fight cancer, and AdHER2DC is an experimental vaccine. ANKTIVA was recently approved for bladder cancer.
The AdHER2DC vaccine targets a protein called HER2, which is found in many endometrial cancer patients (gynecological cancer affecting 65,000+ women in the US each year). This vaccine is made using each patient’s own blood cells. The study is expected to enroll 60 participants and be completed in 2026. It’s sponsored by the National Cancer Institute.
With the company securing reimbursement coverage, all while enrolling patients in clinical trials, Immunitybio Inc. (NASDAQ:IBRX) has immense growth potential. The revenue is projected to grow 51% per annum on average in the next 3 years, compared to a 23% growth forecast for the Biotech industry in the US.
